| Product Name | Bimekizumab |
|---|---|
| CAS | 1418205-77-2 |
| Storage condition | Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light. |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 1 mg | 3-5days | ¥4500.00 | Visible after login | |
| 5 mg | 3-5days | ¥16800.00 | Visible after login | |
| 10 mg | 3-5days | ¥28600.00 | Visible after login | |
| 50 mg | 3-5days | ¥128000.00 | Visible after login | |
| 100 mg | 3-5days | ¥236000.00 | Visible after login |
| Product Name | Bimekizumab |
|---|---|
| CAS | 1418205-77-2 |
| Storage condition | Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light. |
Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F . Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation.